Angiostatin K1-4

Angiostatin Kringles 1-4 Human
Cat. No.
BT620
Source
Human Fluid.
Synonyms
Appearance
Sterile Filtered lyophilized powder.
Purity
Greater than 98.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Human Angiostatin kringles 1-4 is produced from Human Fluid is a glycosylated polypeptide chain which migrates as a doublet 50 kDa on SDS-PAGE.
The Ang K1-4 is purified by proprietary chromatographic techniques.

Product Specs

Introduction
Angiostatin, specifically the fragment comprising kringles 1-4, is a potent inhibitor of angiogenesis. It is a proteolytic fragment derived from plasminogen, and its anti-angiogenic properties stem from its ability to hinder endothelial cell growth. Notably, Angiostatin kringles 1-3 exhibit greater inhibitory activity compared to the kringles 1-4 fragment. The most potent plasminogen fragment is Angiostatin kringles 1-5, demonstrating over 50 times greater inhibitory activity specifically on endothelial cells. Systemic administration of Angiostatin kringles 1-5 effectively inhibits fibrosarcoma growth and significantly reduces neovascularization. Angiostatin is naturally found in mouse serum and urine as a 38 kDa protein fragment consisting of the first four kringle domains of plasminogen. Angiostatin K1-4, also known as plasminogen kringles 1-4 or PK1-4, is generated through the proteolytic cleavage of plasminogen by a serine protease produced by certain prostate carcinoma cell lines. The production of angiostatin by pancreatic cancer cells can be suppressed by TGF-beta 1 in conjunction with plasminogen activator inhibitor type-1 (PAI1).
Description
Human Angiostatin kringles 1-4, derived from Human Fluid, is a glycosylated polypeptide chain that presents as a doublet with a molecular weight of 50 kDa on SDS-PAGE. The purification of Ang K1-4 is achieved through proprietary chromatographic techniques.
Physical Appearance
Sterile Filtered white powder.
Formulation
Lyophilized from a 1 mg/ml solution in 20mM Hepes buffer pH 8.2 and 20mM NaCl.
Solubility
To reconstitute the lyophilized Angiostatin K1-4, it is recommended to dissolve it in sterile 18MΩ-cm H2O to a concentration of at least 100 µg/ml. This solution can then be further diluted in other aqueous solutions as needed.
Stability
Lyophilized Angiostatin Kringles 1-4 remains stable at room temperature for up to 3 weeks; however, it is recommended to store it desiccated below -18°C for long-term preservation. After reconstitution, Angiostatin Kringles 1-4 should be stored at 4°C for 2-7 days. For extended storage, it is advisable to store it below -18°C. To ensure optimal stability during long-term storage, adding a carrier protein such as 0.1% HSA or BSA is recommended. It is essential to avoid repeated freeze-thaw cycles.
Purity
The purity is determined to be greater than 98.0% as assessed by SDS-PAGE analysis.
Biological Activity
Human Angiostatin Kringles 1-4 effectively inhibits basic-FGF-induced endothelial cell proliferation and migration at a concentration range of 300 nM to 1.0 µM.
Source
Human Fluid.

Product Science Overview

Discovery and Structure

Angiostatin was first discovered in the urine of tumor-bearing mice and was later characterized as an internal fragment of plasminogen, a precursor protein involved in the breakdown of blood clots . The angiostatin molecule is composed of the first four kringle domains of plasminogen, hence the name Angiostatin Kringles 1-4 .

Mechanism of Action

Angiostatin exerts its anti-angiogenic effects by inhibiting endothelial cell proliferation, migration, and tube formation, which are essential steps in the angiogenesis process . It achieves this by binding to specific receptors on the surface of endothelial cells, thereby blocking the signaling pathways that promote angiogenesis .

Biological Activity

The biological activity of angiostatin has been extensively studied. It has been shown to inhibit the growth of various tumors by preventing the formation of new blood vessels that supply nutrients and oxygen to the tumor cells . Additionally, angiostatin has anti-inflammatory properties, as it can inhibit the interaction between leukocytes and endothelial cells, thereby reducing inflammation .

Clinical Implications

Given its potent anti-angiogenic and anti-inflammatory properties, angiostatin has been explored as a therapeutic agent for treating cancer and other diseases characterized by excessive angiogenesis and inflammation . For instance, in a humanized-plasminogen mouse model, the administration of angiostatin significantly inhibited tumor growth .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.